• English
  • தமிழ்
  • বাংলা
  • മലയാളം
  • ગુજરાતી
  • हिंदी
  • मराठी
  • Business

The Financial Express

  • Whatsapp Whatsapp Link
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Google News Follow
Watchlist
  • Home
  • Business
  • Markets
  • Market Stats
  • Mutual Funds
  • Money
  • India News
  • Tech
  • US News
  • Shorts
  • ePaper
  • AI Stocks
  • MF Screener
  • Defence Stocks
  • Finance Stocks
  • Gold Rate
  • Silver Rate
  • Breakout Stocks
  • Home
  • Market
    • Stock Insights
    • Cryptocurrency
    • IPO News
    • Stock Market Quotes
    • Indices
    • Nifty 50
    • Sensex
    • Top Gainers
    • Top Losers
    • IPO Stats
  • Market Dashboard
  • Commodities
    • Gold Rate in India
    • Silver Rate in India
    • Petrol Rate in India
    • Diesel Rate in India
  • Opportunity Abroad
  • Money
    • Insurance
    • Income Tax
    • Mutual Funds News
    • MF Screener
  • Economy
  • Business
    • Brand Wagon
    • SME
    • Defence
    • Healthcare
  • Industry
    • Banking & Finance
  • India News
  • World News
  • Trending News
  • Jobs-Career
  • Infrastructure
    • Railways
    • Aviation
    • Roadways
  • Auto
  • Life
    • Lifestyle
    • Entertainment
    • Technology
    • Travel & Tourism
    • Science
  • Sports
  • Opinion
  • Multimedia
    • Photos
    • Web Stories
  • Events
  • ePaper
  • Today’s Paper
  • About us
  • PRIVACY POLICY
  • TERMS AND CONDITIONS
  • Contact Us

  1. Business News
  2. About
  3. pharmaceutical

pharmaceutical

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
A financial graphic showing the Cipla logo with a green 7.9% upward arrow, contrasted against a 55% profit decline chart, highlighting the diverging paths of earnings and share price.
Cipla jumps 8% despite 55% profit drop: Why are brokerages positive on the drugmaker

Cipla surges 8% despite 55% profit drop as brokerages turn bullish—explore if this rally signals a buying opportunity!

May 14, 2026 13:05 IST
3 cash-rich stocks trading 15% to 40% below buyback prices: Signal or value trap?

Promoters are shifting from selling to buying. With $4Bn deployed in 2026, three cash-rich firms offer premiums of up to…

May 7, 2026 05:12 IST
Projects worth $6.1 billion facilitated by Invest India in FY26: 42% of capital comes from Europe, drives job creation in MP, Rajasthan

Invest India facilitated $6.1 billion across 60 projects in FY26, generating over 31,000 jobs and signalling a shift toward high-value…

April 30, 2026 23:57 IST
Small caps, big moats: Decoding Mukul Agrawal’s bet on precision manufacturing and CDMOs

Shift toward niche, high-skill businesses is shaping investor strategy, with precision manufacturing and CDMO firms gaining traction despite smaller scale.

April 29, 2026 05:15 IST
3 Undervalued Pharma Stocks to Add to Your 2026 Watchlist
3 Undervalued Pharma Stocks to Add to Your 2026 Watchlist

A look at some of the undervalued pharma stocks in India.

April 27, 2026 14:52 IST
sun pharma us tariff exposure jefferies report
US Tariff concerns: Jefferies explains why Sun Pharma could face the biggest hit—But not the worst outcome

Sun Pharma may be the most exposed to US tariffs but a global buffer could quietly limit the real damage.

April 3, 2026 07:55 IST
Nifty Pharma fall today US tariff impact Sun Pharma Cipla decline
Why are pharma stocks falling today? Nifty Pharma down 3%; Sun Pharma, Cipla, Apollo Hospitals fall as much as 4%

Pharma stocks fall as Nifty Pharma drops 3%. Sun Pharma, Cipla slide amid US tariff fears and export risk concerns.

April 2, 2026 10:56 IST
₹1,000 cr to ₹5,000 cr: 3 pharma stocks to watch for India’s GLP-1 explosion by 2030

A ₹1,000 crore market is set to grow 5x to ₹5,000 crore by 2030 as prices drop 40–50% post patent…

March 31, 2026 05:27 IST
A financial chart showing the India VIX surging to 27, its highest since the Russia-Ukraine war, alongside a list of oversold stocks like HDFC Bank and ICICI Bank poised for a relief rally.
Monday Watchlist: Sun Pharma, HDFC Bank, ICICI, and 7 stocks to watch – VIX hits 2-year high

Monday watchlist, March 30: Track Sun Pharma, HDFC Bank and ICICI as market volatility surges; review key stock setups and…

March 30, 2026 05:30 IST
Govt cracks down on unauthorised sales of weight-loss drugs after generics hit the market

India ramps up enforcement against unauthorised sale and promotion of GLP-1 weight-loss drugs after generics hit the market, with inspections…

March 24, 2026 20:35 IST
Avnish Chabaria, founder of Wellbeing Nutrition
Failures, 600 formulas, one breakthrough: The ‘Ironman’ mindset behind Avnish Chhabria’s Rs 1,583 crore startup exit

An endurance question turned into a consumer nutrition business, Built through failed trials, a stalled export, and a restart in…

March 22, 2026 19:30 IST
Indian Pharma Giants Launch Affordable Generic Semaglutide for Diabetes and Weight Loss
Indian pharma giants launch low-cost generic semaglutide injections 

Following the patent expiry of semaglutide in India, leading pharma companies including Sun Pharma, Dr Reddy’s, Zydus, and Glenmark have…

March 21, 2026 19:38 IST
semaglutide india pharma stocks ozempic patent expiry
Sun Pharma to Cipla: 7 pharma stocks gear up for Rs 5,000 cr semaglutide opportunity after patent expiry

Ozempic patent expiry has triggered a fresh pharma race in India. Sun Pharma, Cipla, and Dr Reddy’s are among 7…

March 20, 2026 17:58 IST
HSBC sees Glenmark gaining after US FDA nod boosts inhaler pipeline
Glenmark Pharma: HSBC sees 21% upside after ‘first-to-market’ US FDA win

A key US drug approval is putting this pharma stock back on the radar, with a global brokerage pointing to…

Updated: March 18, 2026 14:12 IST
A high-quality graphic showing a Biocon-branded Liraglutide prefilled pen alongside the US FDA logo, with a background stock chart showing Biocon's upward trend and a target price highlight of Rs 480.
Not just Ozempic: Biocon shares in focus after USFDA clears GLP-1 Liraglutide injection – What it means

Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!

March 13, 2026 06:58 IST
Beyond Adani & Concor: 3 hidden logistics plays powering India’s export engine

This article explores the burgeoning intersection of India’s trade momentum and the logistics sector. With cumulative exports reaching $720.8 billion…

March 10, 2026 05:27 IST
Not Cipla, Not Lupin: 2 high-ROCE pharma ‘compounders’ with non-stop quarterly profit growth

While Nifty Pharma giants struggle with regulatory headwinds and pricing pressures, two outliers are quietly catching the attention of smart…

March 10, 2026 05:24 IST
A professional stock market candlestick chart showing Nifty 50 and Bank Nifty price action with 20-day and 200-day moving average overlays and RSI momentum indicators.
Monday Watchlist: Is Nifty heading for meltdown in March? HDFC Bank, SBI, Tata Steel, Vedanta in focus

Markets watchlist today, March 09: Nifty faces bearish pressure this March; watch HDFC Bank, SBI, Tata Steel, and Vedanta for…

March 9, 2026 05:40 IST
  • Next »

Related News

"The glory of man," he said, with the ease of someone who has earned the right to the line, "is not in never falling or failing, but in rising each time you fall."
How a schoolteacher’s son transformed Indian air travel with 2 old planes and Rs 5 crore
'Remove Uber, Ola, Rapido apps': Maharashtra govt issues notices to Apple and Google amid tussle over bike-taxis
‘Remove Uber, Ola, Rapido apps’: Maharashtra govt issues notices to Apple and Google amid tussle over bike-taxis
Ankur Warikoo’s Big Exit: Shuts Profitable ₹100 Crore Courses Platform
Ankur Warikoo shuts down Rs 100 crore courses empire – ‘Makes no sense to continue’
Navi Mumbai Airport Crosses 150 Daily Flights: Rapid Scaling Shifts Focus to Suburban Commute Bottlenecks
Navi Mumbai airport’s next challenge moves beyond runway capacity
Clavis EV and Clavis ICE
How an EV delivered a mind-bending 89 km/l: The math behind EV efficiency
shorts
Amitabh Bachchan shares rare visuals of Bandar Abbas Vishnu temple in Iran
Amitabh Bachchan shares rare visuals of Bandar Abbas Vishnu temple in Iran
Life22 min ago

Amitabh Bachchan’s Instagram post about the Vishnu Temple in Bandar Abbas, Iran has sparked a conversation about the fusion of Islamic and Hindu architecture and the strong connection between India and Iran. Fans have praised the actor for bringing attention to the temple and emphasizing the need to preserve cultural heritage and religious diversity.

View all shorts

Trending Topics

defence stocks
Gold rate today
Silver rate today
AI stocks
mutual funds
semiconductor stocks

Top Categories
  • Market
  • India News
  • Stock Insights
  • Money
  • Opportunities Abroad
  • World News
  • Latest News
  • Technology
  • ITR Guide
  • Money Insights
Stock Screeners
  • Stock Screener
  • Break Out Stocks
  • Defence Stocks
  • Consistently Growing Stocks
  • Low Price Blue Chip Stocks
Top NSE/BSE Companies Share Price
  • Tata Motors share price
  • Tata Steel share price
  • State Bank Of India share price
  • HDFC Bank share price
  • Infosys share price
  • ITC share price
  • Wipro share price
  • NTPC share price
  • ongc share price
  • Adani Enterprises share price
  • Adani Ports and Special Economic Zone share price
  • Bharat Petroleum Corporation share price
  • Coal India share price
  • Bajaj Finance share price
  • ICICI Bank share price
  • Titan Company share price
  • Larsen & Toubro share price
  • Power Grid Corporation Of India share price
  • Asian Paints share price
Gold Price in Top Metro Cities
  • Gold Rate Today
  • Gold Rate in Dubai
  • Gold Rate in Chennai
  • Gold Rate in Kerala
  • Gold Rate in Hyderabad
  • Gold Rate in Bangalore
  • Gold Rate in Mumbai
  • Gold Rate in Noida
  • Gold Price in Delhi
  • Gold Price in Ahmedabad
  • Gold Price in Kolkata
Latest News
  • Amitabh Bachchan shares rare visuals of Iran’s first Hindu temple
  • Fast fashion, lean stock at startups
  • Two-wheeler makers line up Rs 11,000 crore capex
  • Who is Manish Dwivedi? Merchant navy officer from UP goes missing near US port
  • L’affaire Tata: New court battle looms
Follow Us
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Download Apps
  • Play_stor Play_stor Link
  • Apple_stor Apple_stor Link
Express Group
  • INDIAN EXPRESS GROUP
  • The Indian Express
  • Loksatta
  • Jansatta
  • Inuth
  • Ramnath Goenka Awards
  • IE Tamil
  • IE Malayalam
  • IE Bangla
  • IE Gujarati
  • IE Education
  • This website follows the DNPA’s code of conduct
Quick Links
  • T&C
  • Privacy Policy
  • CONTACT US
  • About Us
Copyright © 2026 The Indian Express [P] Ltd. All Rights Reserved
Market Pulse